Inventor · disambiguated record
Liangzhi Xie
Also filed as: XIE LIANGZHI
6 granted patents·16 pending applications·3 citations·filing 2003–2024
70Inventor score
Top patents by PatentIndex Score
22 records- 0189US12060416B2Humanized anti-VEGF monoclonal antibodySINOCELLTECH LTD·Filed 2022·Granted Aug 13, 2024·2 cites·9 claims
- 0286US2025122246A1Chimeric papillomavirus l1 proteinSINOCELLTECH LTD·Filed 2024·Application pending·0 cites
- 0386US2025109174A1Chimeric papillomavirus l1 proteinSINOCELLTECH LTD·Filed 2024·Application pending·0 cites
- 0486US2025145672A1Chimeric papillomavirus l1 proteinSINOCELLTECH LTD·Filed 2024·Application pending·0 cites
- 0586US2025101068A1Chimeric papillomavirus l1 proteinSINOCELLTECH LTD·Filed 2024·Application pending·0 cites
- 0686US2025171506A1Chimeric papillomavirus l1 proteinSINOCELLTECH LTD·Filed 2024·Application pending·0 cites
- 0786US2025136645A1Chimeric papillomavirus l1 proteinSINOCELLTECH LTD·Filed 2024·Application pending·0 cites
- 0886US2025122245A1Chimeric papillomavirus l1 proteinSINOCELLTECH LTD·Filed 2024·Application pending·0 cites
- 0986US2025136644A1Chimeric papillomavirus l1 proteinSINOCELLTECH LTD·Filed 2024·Application pending·0 cites
- 1086US2025145671A1Chimeric papillomavirus l1 proteinSINOCELLTECH LTD·Filed 2024·Application pending·0 cites
- 1186US2025136646A1Chimeric papillomavirus l1 proteinSINOCELLTECH LTD·Filed 2024·Application pending·0 cites
- 1286US2025092096A1Chimeric papillomavirus l1 proteinSINOCELLTECH LTD·Filed 2024·Application pending·0 cites
- 1376US12139514B2Chimeric papilloma virus L1 proteinSINOCELLTECH LTD·Filed 2022·Granted Nov 12, 2024·0 cites·8 claims
- 1464US7344873B2Methods of adenovirus productionMERCK & CO INC·Filed 2003·Granted Mar 18, 2008·1 cites·8 claims
- 1563US2024158474A1Anti-hpv6 l1 protein antibody and detection method using the antibodySINO BIOLOGICAL INC·Filed 2023·Application pending·0 cites
- 1653US12440549B2Polyvalent immunogenicity composition for human papillomavirusSINOCELLTECH LTD·Filed 2022·Granted Oct 14, 2025·0 cites·7 claims
- 1752US12479911B2Humanized anti-VEGF antibody Fab fragmentSINOCELLTECH LTD·Filed 2022·Granted Nov 25, 2025·0 cites·5 claims
- 1850US12275790B2Humanized anti-PD-1 antibody and the use thereofSINOCELLTECH LTD·Filed 2021·Granted Apr 15, 2025·0 cites·22 claims
- 1947US2022259316A1Multiple-Variable Dosage Regimen for the Treatment of Cancers with High Expression of EGFRSINOCELLTECH LTD·Filed 2022·Application pending·0 cites
- 2047US2023257469A1TGFßR2 EXTRACELLULAR DOMAIN TRUNCATED MOLECULE, FUSION PROTEIN OF TGFßR2 EXTRACELLULAR DOMAIN TRUNCATED MOLECULE AND ANTI-EGFR ANTIBODY, AND ANTI-TUMOR USE OF FUSION PROTEINSINOCELLTECH LTD·Filed 2021·Application pending·0 cites
- 2147US2005118701A1Large scale methods of producing adenovirus and adenovirus seed stocksFiled 2003·Application pending·0 cites
- 2246US2023330220A1Method for improving immunogenicity of protein/peptide antigenSINOCELLTECH LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Liangzhi Xie files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →